- The folks at National Cancer Institute (NCI) are studying the effects of vorinostat; stereotactic body radiation therapy; laboratory biomarker analysis; pharmacological study; therapeutic conventional surgery on Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Adult Mixed Glioma and Recurrent Adult Brain Tumor in individuals ages 18 years and older. This clinical trial is slated to start June 2012.
This study is officially titled, "High-Dose Vorinostat With Radiation Therapy in the Treatment of Recurrent Glioma."
|Recruiting||Thomas Jefferson University Hospital|
Philadelphia, Pennsylvania, 19107
United States - map
For more study details, please visit this link to ClinicalTrials.gov record, which is the source of this webpage.